Starting July 1, 2026, Maine’s Universal Immunization Program will expand vaccine access to all adults 19-64 years, including those who are underinsured, uninsured, or enrolled in MaineCare. A universal immunization program will provide many benefits to both healthcare providers and patients.
As a currently enrolled Vaccines for Children (VFC) and or Adult 317 provider, you will automatically be eligible to begin ordering adult vaccines. Adult vaccines will be added into your existing order set – no separate enrollment is required.
The only new requirement for currently enrolled providers is to submit vaccine administration numbers from the previous year (2025). This will help us estimate vaccine need for the upcoming year. If you have not administered vaccines to adults, but wish to as we move forward, please submit your best estimation for adults 19-64 in your practice that may be eligible for vaccination. Please use the following link to document your totals:Adult Vaccine Need Assessment.
For currently enrolled providers, Click here to complete the Adult Vaccine Need Assessment by June 30, 2026.
Upcoming Informational Webinars
Join us to find out more about Maine’s Universal Immunization Program. We will be hosting informational sessions on the following dates:
We thank you for your continued partnership and look forward to working with you as we roll out this program. Contact the Maine Immunization Program if you have any questions about your status as a provider.
Nominate an immunization champion today! The 2026 Immunization Champion Award recognizes individuals doing an exemplary job or going above and beyond to promote or foster immunization in their community. The award is hosted by the Association Immunization Managers (AIM) and honors an individual from each of the 66 immunization program jurisdictions.
Anyone can nominate an Immunization Champion! Nominees’ experience can be focused on adult, adolescent, and/or child immunizations. The final champions are selected by their local or state immunization programs, who evaluate nominees by their immunization work through the following criteria:
Leadership
Collaboration
Innovation
Advocacy
Visit the AIM website to learn more about the Immunization Champion Award and stay up to date with announcements. If you have any questions, please contact Caitlin Anton at caitlin.anton@maine.gov.
When a vaccine shipment arrives, be sure to review it right away. Check the vaccines against the packing list to confirm everything was received, inspect the vaccines and temperature monitoring device, and make sure any required diluent is included.
Vaccines should be stored immediately upon receipt to maintain viability. Be sure to check expiration dates and rotate stock so short-dated vaccines are used first and accept the shipment in ImmPact as soon as possible. If the shipment is not accepted within 5 days of arrival, an ImmPact staff will accept the order on your behalf.
Please contact MIP immediately if the correct quantity or type of vaccine or diluent was not received, if vaccines were received in error or if there is any concern that the vaccines may have been compromised. If the temperature monitor indicates an issue, or the cold chain may have been affected, follow the guidance for vaccines received warm or questionable.
The Vaccinate Your Family (VYF) University now has free educational courses available to health care providers. In this free course, you’ll discover proven strategies to make vaccine conversations routine, effective, and empathetic. Through real-world examples and interactive practice, you’ll gain the tools and confidence to have effective vaccine conversations. This course is self-paced, available 24/7, and launched in December 2025.
Healthcare facilities in Maine are advised to continue to make RSV monoclonal antibody products (nirsevimab or clesrovimab) available to patients and eligible infants through April 30. This represents an extension beyond the typical end date of March 30, reflecting the prolonged circulation of RSV this year.
Respiratory Syncytial Virus (RSV) activity in Maine is peaking later and lasting longer than in recent years. RSV is the leading cause of infant hospitalization in the U.S. For updated information on RSV circulation, see the Maine CDC Respiratory Virus Dashboard.
If you have any questions, please contact the Maine Immunization Program at: Main Line: (207) 287-3746 ImmPact Helpdesk: (207) 287-3006 / Support/Education: (207) 287-9972
